Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study.

@article{Finkelmeier2014Severe2D,
  title={Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study.},
  author={Fabian Finkelmeier and Bernd Kronenberger and Verena Koeberle and Joerg Bojunga and Stefan Zeuzem and Joerg Trojan and Albrecht Piiper and Oliver B. Waidmann},
  journal={Alimentary pharmacology & therapeutics},
  year={2014},
  volume={39 10},
  pages={1204-12}
}
BACKGROUND Vitamin D is involved in many biological processes. The role of vitamin D in patients with hepatocellular carcinoma (HCC) remains inconclusive, although there is evolving evidence that vitamin D may modulate cancer development and progression. AIM To evaluate serum vitamin D as prognostic parameter in HCC, we performed a prospective cohort study. METHODS HCC patients were prospectively recruited and 25-hydroxyvitamin D3 (25(OH)D3 ) levels were determined. 25(OH)D3 levels were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Statistics Subcommittee of the NCIEORTC

  • LM McShane, DG Altman, W Sauerbrei, SE Taube, M Gion, GM Clark
  • Working Group on Cancer Aliment Pharmacol Ther
  • 2014

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma

  • O Waidmann, V K€oberle, D Bettinger
  • J Hepatol
  • 2013

Similar Papers

Loading similar papers…